Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy
article
OA: bronze
CC0
⤵ 4 in-corpus citations
AI-generated summary
This study investigated the effects of continuous combined hormone therapy on mammographic breast density, estrogen, progesterone, and IGF-1 levels in postmenopausal women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo study the effect on mammographic breast density of two different continuous combined regimens for hormone therapy.DesignRandomized clinical study.SettingUniversity hospital.Patient(s)Postmenopausal women without any previous history of breast disorder.Intervention(s)The women received either estradiol valerate/dienogest or estradiol/norethisterone acetate. Mammograms and venous blood samples were obtained at baseline and after 6 months.Main outcome measure(s)Change in mammographic breast density. Correlations with levels of hormones, growth factors, and binding proteins.Result(s)An increase in mammographic density was recorded in approximately 50% of the women, and there were no differences between treatments. Increased density showed a positive correlation with estradiol, estrone, and sex hormone-binding globulin and showed a negative association to free T. Among hormonal factors, levels of free T were the most important for predicting increased density.Conclusion(s)Continuous combined hormone therapy with different progestogens has a marked impact on the breast.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest<sup>®</sup>for continuous combined hormone replacement therapy in postmenopausal women 2000
- Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest<sup>®</sup>for continuous combined hormone replacement therapy in postmenopausal women 2000
Cited by (4)
- Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis 2005
- The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis 2012
- Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs) 2006
- Effects of Dienogest on Breasts of Women of Reproductive Age: A Cohort Study 2022
References (52)
- Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest<sup>®</sup>for continuous combined hormone replacement therapy in postmenopausal women via crossref
- Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest<sup>®</sup>for continuous combined hormone replacement therapy in postmenopausal women via openalex
- doi:10.7326/0003-4819-130-4_part_1-199902160-00003 via openalex
- doi:10.1210/jcem.84.12.6194 via openalex
- doi:10.1023/a:1006482418082 via openalex
- doi:10.1016/s0015-0282(98)00042-9 via openalex
- doi:10.1210/jcem.86.1.7269 via openalex
- doi:10.1016/s0748-7983(97)80148-5 via openalex
- doi:10.1067/mob.2002.122852 via openalex
- doi:10.1001/jama.288.3.321 via openalex
- doi:10.1097/00006250-200304000-00043 via openalex
- doi:10.1016/s0029-7844(02)02503-6 via openalex
- doi:10.1210/jcem.81.8.8768841 via openalex
- doi:10.1358/dot.1996.32.1.354181 via openalex
- doi:10.2214/ajr.126.6.1130 via openalex
- doi:10.1016/s0140-6736(97)10384-1 via openalex
- doi:10.1016/s0140-6736(03)14065-2 via openalex
- doi:10.1016/s0002-9378(99)70560-0 via openalex
- doi:10.1080/13697130310001651472 via openalex
- doi:10.1007/978-1-4684-2301-3_8 via openalex
- doi:10.1038/sj.bjc.6600537 via openalex
- W6648250805 via openalex
- W6679241261 via openalex
- W6684904466 via openalex
- doi:10.1007/978-3-642-45769-2_6 via openalex
- doi:10.1080/cmt.4.1.42.48 via openalex
- doi:10.1016/s0029-7844(02)02502-4 via openalex
- doi:10.1016/s0960-0760(01)00185-6 via openalex
- doi:10.1038/sj.bjc.6600537 via crossref
- doi:10.1016/s0140-6736(03)14065-2 via crossref
- doi:10.1016/s0002-9378(99)70560-0 via crossref
- doi:10.7326/0003-4819-130-4_part_1-199902160-00003 via crossref
- doi:10.1016/s0002-9378(96)70379-4 via crossref
- doi:10.1210/jcem.86.1.7269 via crossref
- doi:10.1016/s0748-7983(97)80148-5 via crossref
- doi:10.1001/jama.288.3.321 via crossref
- doi:10.2214/ajr.126.6.1130 via crossref
- doi:10.1016/0022-4731(82)90038-3 via crossref
- doi:10.1067/mob.2002.122852 via crossref
- doi:10.1080/cmt.4.1.42.48 via crossref
- doi:10.1023/a:1006482418082 via crossref
- doi:10.1007/978-3-642-45769-2_6 via crossref
- doi:10.1016/s0140-6736(97)10384-1 via crossref
- doi:10.1016/s0960-0760(01)00185-6 via crossref
- doi:10.1097/01.gme.0000055522.67459.89 via crossref
- doi:10.1080/13697130310001651472 via crossref
- doi:10.1023/a:1022987618445 via crossref
- doi:10.1016/s0015-0282(98)00042-9 via crossref
- doi:10.1097/01.gme.0000055522.67459.89 via openalex
- doi:10.1023/a:1022987618445 via openalex
- doi:10.1016/s0002-9378(96)70379-4 via openalex
- doi:10.1016/0022-4731(82)90038-3 via openalex
Cited by (4)
- Effects of Dienogest on Breasts of Women of Reproductive Age: A Cohort Study 2022
- The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis 2012
- Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs) 2006
- Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis 2005
Source provenance
- crossref
- last seen: 2026-05-16T01:00:06.581567+00:00
- openalex
- last seen: 2026-05-14T06:05:00.350814+00:00
License: CC0
· commercial use OK